| HCAT |
Health Catalyst, Inc. |
Common Stock, $0.01 par value |
20% |
$41,210,964 |
-$137,918 |
13,922,623 |
-0.33% |
Mathew P. Arens |
01 Dec 2025 |
| MASS |
908 Devices Inc. |
Common Stock, $0.001 par value |
17% |
$33,397,591 |
+$8,120,952 |
6,184,739 |
+32% |
Mathew P. Arens |
31 Dec 2025 |
| PHLT |
Performant Healthcare, Inc. |
Common Stock, $0.01 par value |
16% |
$53,117,291 |
|
12,923,915 |
|
Mathew P. Arens |
30 Jun 2025 |
| SLP |
Simulations Plus, Inc. |
Common Stock, $0.001 par value |
13% |
$48,307,294 |
|
2,649,879 |
|
First Light Asset Management, LLC |
31 Jan 2026 |
| AXGN |
Axogen, Inc. |
Common Stock, $0.01 par value |
13% |
$105,980,875 |
+$23,458,744 |
5,940,632 |
+28% |
Mathew P. Arens |
30 Sep 2025 |
| SIBN |
SI-BONE, Inc. |
Common Stock, $0.001 par value |
12% |
$93,070,224 |
|
5,170,568 |
|
Mathew P. Arens |
30 Nov 2025 |
| KRMD |
KORU Medical Systems, Inc. |
Common Stock, $0.01 par value |
8.3% |
$21,417,945 |
-$5,550,194 |
3,831,475 |
-21% |
Mathew P. Arens |
31 Dec 2025 |
| NEO |
Neogenomics, Inc. |
Common Stock, $0.01 par value |
7.6% |
$73,287,770 |
|
9,784,749 |
|
Mathew P. Arens |
30 Jun 2025 |
| PVLA |
PALVELLA THERAPEUTICS, INC. |
Common Stock, $0.01 par value |
7.5% |
$89,137,745 |
|
887,031 |
|
First Light Asset Management, LLC |
31 Dec 2025 |
| ANAB |
AnaptysBio Inc. |
Common Stock, $0.01 par value |
3.1% |
$26,474,603 |
-$42,907,347 |
864,618 |
-62% |
Mathew P. Arens |
30 Sep 2025 |
| ORGO |
Organogenesis Holdings Inc. |
Common Stock, $0.01 par value |
3.1% |
$16,371,915 |
-$18,610,675 |
3,888,816 |
-53% |
Mathew P. Arens |
31 Dec 2025 |
| FNA |
Paragon 28, Inc. |
Common Stock, $0.01 par value |
1.7% |
$18,718,661 |
-$119,897,999 |
1,429,997 |
-86% |
Mathew P. Arens |
28 Feb 2025 |
| OPRX |
OptimizeRx Corporation |
Common Stock, $0.01 par value |
0% |
$0 |
|
0 |
|
First Light Asset Management, LLC |
31 Dec 2024 |